Development and invitro evaluation of fast dissolving tablets of glipizide

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 1, Issue SUPPL. 1, 2009, Pages 145-150

  Patel, Biraju ^a   Patel, Dhaval ^a   Parmar, Ramesh ^a   Patel, Chirag ^a   Serasiya, Tejas ^b   Sanja, S D ^c  

^a Veerayatan Institute of Pharmacy   (India)

^b Smt R B Patel Mahila Pharmacy College   (India)

^c B K Mody Government Pharmacy College   (India)

Author keywords

Direct compression; Fast dissolving tablets; Glipizide; Superdisintegrants

Indexed keywords

CROSCARMELLOSE SODIUM; CROSPOVIDONE; GLIPIZIDE;

ARTICLE; COMPRESSION; CONTROLLED STUDY; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; HARDNESS; HUMAN; IN VITRO STUDY; LIPID SOLUBILITY; TABLET; WEIGHT;

EID: 77953380788     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. H Seager. Drug delivery products and zydis fast dissolving dosage form. J. Pharm. Pharmacol 1990; 50: 375-382.
2. RK Chang, X Guo, BA Burnside, RA Cough. Fast dissolving tablets. Pharm Tech 2000; 24: 52-58.
3. L Dobetti. Fast-melting tablets: Developments and technologies. Pharma Tech. Suppl 2001; 44-50.
4. BS Kuchekar, V. Arumugam. Fast dissolving tablets. Indian J Pharm Educ 2001; 35: 150-152.
5. th ed. New Delhi: Medical Publishers (p) Ltd.; 1999. p. 142-44.
6. BS Kuchekar, AC Badhan, HS Mahajan. Mouth dissolving tablets of salbutamol sulphate: A novel drug delivery system. Indian Drugs 2004 41: 592-598.
7. rd ed. Mumbai: Varghese Publishing House; 1987. p. 293-99.
8. SA Sreenivas, AP Gadad, MB Patil. Formulation and Evaluation of Ondasetron hydrochloride directly compressed mouth disintegrating tablets. Indian Drugs 2006; 43: 35-37.
9. United State Phamacopeia Convention. NF Ashian edition; 2004. p 74-5.
10. Guidance for Industry, 2003. Q1A(R2) Stability Testing of New Drug Substances and Products, U.S. Department of health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), November 2003, ICH, Revision 2.